SCHEMBL6562115

SCHEMBL6562115

Nc1ccc(Cl)c(S(=O)(=O)NCCO)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 1/20 0.43
CXCR2 P25025 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP2C19 P33261 3/20 0.39
GAA P10253 2/20 0.38
PKM P14618 2/20 0.38
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEP1B Q16820 1/20 0.35
CSNK1A1 P48729 2/20 0.35
CSNK1D P48730 1/20 0.35
CSNK1E P49674 1/20 0.35
CSNK1G2 P78368 1/20 0.35
CSNK1G1 Q9HCP0 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565726 0.87 CA12 (0.46) CXCR2ALDH1A1CYP2C19GAAMEP1B
SCHEMBL27552122 0.84 FABP4 (0.42) CXCR2ALDH1A1MEP1B
SCHEMBL6565765 0.83 VCAM1 (0.41) CXCR2ALDH1A1GAAPKMCYP3A4
SCHEMBL6564241 0.83 TSHR (0.50) CXCR2ALDH1A1CYP2C19GAAPKM
SCHEMBL6565584 0.83 CXCR2 (0.56) GSTO1CXCR2ALDH1A1GAAPKM
SCHEMBL6563454 0.81 CXCR2 (0.44) GSTO1CXCR2ALDH1A1GAAL3MBTL1
SCHEMBL6565796 0.81 LMNA (0.40) GSTO1CXCR2ALDH1A1CYP2C19GAA
SCHEMBL6563387 0.80 CXCR2 (0.43) GSTO1CXCR2ALDH1A1GAAHPGD
SCHEMBL6563375 0.79 PIK3CD (0.39) CXCR2ALDH1A1MEP1BPIK3CDPIK3CG
SCHEMBL6562097 0.79 PDK1 (0.37) CXCR2ALDH1A1CYP2C19GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161232-B1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2004-03-24 EP disclosed
US-20030109527-A1 Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2003-06-12 US disclosed
US-6500863-B1 INTERLEUKIN BINDING INHIBITORS SUCH AS N-(2-HYDROXYL-3-AMINO SULFONYL-4-CHLOROPHENYL)-N'-(2-BROMOPHENYL)UREA, USED FOR PROPHYLAXIS OF CHEMOKINE MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION 2002-12-31 US disclosed
EP-1161232-A4 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-09-18 EP disclosed
CN-1334726-A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-02-06 CN disclosed
EP-1161232-A1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2001-12-12 EP disclosed
WO-2000035442-A1 HYDROXY DIPHENYL UREA SULFONAMIDES AS IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109527-A1 Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists CXCL8, CCR8, IL18 GSTO1 2909/4885CXCR2 26/4885ALDH1A1 1321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.